Andrew D. Ashe - 16 Jun 2021 Form 3 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
President, Chief Operating Officer Exhibit Index: 24.1 Power of Attorney
Signature
/s/ Andrew Ashe
Issuer symbol
VERV
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
3
Filing time
16 Jun 2021, 19:23:27 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VERV Common Stock 166,722 16 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 107,997 $8.24 Direct F1
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 164,113 $2.87 Direct F2
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 60,748 $1.48 Direct F3
holding VERV Stock Option (right to buy) 16 Jun 2021 Common Stock 51,203 $1.39 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 12, 2021 for 107,997 shares. 25% of the shares underlying the option will vest on February 1, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until February 1, 2025.
F2 The option was granted on September 16, 2020 for 164,113 shares. 25% of the shares underlying the option will vest on September 16, 2021, and the remainder are scheduled to vest in equal monthly installments thereafter until September 16, 2024.
F3 The remaining shares underlying this option, which was granted on September 17, 2019, vest over 4 years in equal monthly installments through July 26, 2023.
F4 The remaining shares underlying this option, which was granted on November 8, 2018, vest in equal monthly installments until August 20, 2022.

Remarks:

President, Chief Operating Officer Exhibit Index: 24.1 Power of Attorney